Enbrel (Immunex Corp) en es it fr

Enbrel (Immunex Corp) Brand names, Enbrel (Immunex Corp) Analogs

Enbrel (Immunex Corp) Brand Names Mixture

  • No information avaliable

Enbrel (Immunex Corp) Chemical_Formula


Enbrel (Immunex Corp) RX_link


Enbrel (Immunex Corp) fda sheet

Enbrel (Immunex Corp) msds (material safety sheet)

Enbrel (Immunex Corp) Synthesis Reference

No information avaliable

Enbrel (Immunex Corp) Molecular Weight


Enbrel (Immunex Corp) Melting Point

71 oC (whole mAb) - Vermeer, A.W.P. & Norde, W., Biophys. J. 78:394-404 (2000).

Enbrel (Immunex Corp) H2O Solubility

No information avaliable

Enbrel (Immunex Corp) State


Enbrel (Immunex Corp) LogP


Enbrel (Immunex Corp) Dosage Forms

Kit;liquid;powder for solution

Enbrel (Immunex Corp) Indication

For treatment of severe adult and juvenille rheumatoid arthritis

Enbrel (Immunex Corp) Pharmacology

Used in the treatment of rheumatoid arthritis and the reduction of the adverse effects of tumor necrosis factor (TNF). TNF is a naturally occurring cytokine that is involved in normal inflammatory and immune responses. Elevated levels of TNF are found in tissues and fluids of patients with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis (AS), and plaque psoriasis. Etanercept binds specifically to tumor necrosis factor (TNF) and blocks its interaction with cell surface TNF receptors.

Enbrel (Immunex Corp) Absorption

No information avaliable

Enbrel (Immunex Corp) side effects and Toxicity

No information avaliable

Enbrel (Immunex Corp) Patient Information


Enbrel (Immunex Corp) Organisms Affected

Humans and other mammals